Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Abeona Therapeutics Inc shares valued at $76,669 were sold by Silverstein Christine Berni on Jul 09 ’25. At $5.86 per share, Silverstein Christine Berni sold 13,093 shares. The insider’s holdings dropped to 120,479 shares worth approximately $0.8 million following the completion of this transaction.
Also, Seshadri Vishwas sold 69,420 shares, netting a total of over 406,503 in proceeds. Following the sale of shares at $5.86 each, the insider now holds 1,234,341 shares.
Before that, Vazzano Joseph Walter had sold 25,411 shares from its account. In a trade valued at $148,799, the Chief Financial Officer traded Abeona Therapeutics Inc shares for $5.86 each. Upon closing the transaction, the insider’s holdings decreased to 25,411 shares, worth approximately $3.18 million.
Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in early March. As of July 03, 2024, H.C. Wainwright has initiated its “Buy” rating for ABEO. Earlier on May 30, 2024, Stifel initiated its rating. Their recommendation was “a Buy” for ABEO stock.
Analyzing ABEO Stock Performance
On last trading session,, Abeona Therapeutics Inc [NASDAQ: ABEO] rose 5.91% to $6.63. The stock’s lowest price that day was $6.22, but it reached a high of $6.715 in the same session. During the last five days, there has been a surge of approximately 13.33%. Over the course of the year, Abeona Therapeutics Inc shares have jumped approximately 23.01%.
Support And Resistance Levels for Abeona Therapeutics Inc (ABEO)
RSI (Relative Strength Index) is 67.60 on the 14-day chart, showing neutral technical sentiment.
Is Abeona Therapeutics Inc subject to short interest?
Stocks of Abeona Therapeutics Inc saw a sharp rise in short interest on 2025-06-13 jumping by 0.57 million shares to 6.46 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 5.89 million shares. A jump of 8.82% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.44 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.44.
Which companies own the most shares of Abeona Therapeutics Inc (ABEO)?
In terms of Abeona Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 18 in the next 12 months, up nearly 187.54% from the previous closing price of $6.26. Analysts anticipate Abeona Therapeutics Inc stock to reach 20 by 2025, with the lowest price target being 16. In spite of this, 2 analysts ranked Abeona Therapeutics Inc stock as Buy at the end of 2025. On November 11, 2020, Cantor Fitzgerald assigned a price target of “an Overweight” to the stock and upgraded coverage with a $4.
